top of page
Insights for Life Sciences Talent Leaders
Strategic guidance on life sciences executive recruitment and human capital for search partners, biotech innovators, and scale-up HR leaders. I also share occasional personal reflections on the industry.


Remember, Remember the Fifth of November: Biotech’s Fireworks, Sparks and Slow Burns
Remember, remember the fifth of November—the night when bonfires burn, fireworks light the sky and everyone looks up to see what will explode next. Biotech has its own Fireworks Night. This year’s display featured headline-grabbing rockets: GLP‑1 deals, gene editing milestones, renewed enthusiasm for RNA and a more disciplined wave of AI‑in‑drug‑discovery stories. But, as every investor knows, not everything that launches reaches the same height.
For biotech insiders and inv
sharonshieldsconsu
Nov 53 min read


How AI Is Transforming Clinical Development Drug Discovery Recruitment and Trial Management
Clinical development has always carried a painful contradiction. Science can point to promising biology, yet turning that promise into a tested therapy can take years of trial design, patient matching, site coordination and regulatory work. Many compounds fail late. Many trials struggle to enrol. Many teams spend too much time searching for patterns that sit hidden in papers, scans, genomic files and electronic health records.
sharonshieldsconsu
Oct 239 min read


Redefining Neurodegeneration: From Plaques and Pathology to Systemic Network Dysfunction
From Single Targets to Systems Biology: A New Framework for Neurodegenerative R&D
For three decades, neurodegeneration programmes have been built around a tightly focused premise: find the toxic protein, clear it from the brain, protect the vulnerable neuron. Alzheimer’s was framed as an amyloid and tau problem. Parkinson’s as a dopamine and alpha-synuclein problem. ALS as a motor neuron problem.
That framing has driven real progress – from disease-modifying antibodies to g
sharonshieldsconsu
Sep 75 min read


The Growing Momentum Behind Neurodegenerative Disease Research
How innovation, investment and talent are advancing Alzheimer's disease and other neurological disorders Intricate digital rendering of a brain, with a network-like structure against a dark background, highlighting the complexity of neural connections. My interest in neuroscience and neurodegenerative diseases stems from both professional and personal experience. My first step into executive search was through a Talent Acquisition role at a pharmaceutical neuroscience researc
sharonshieldsconsu
Jul 34 min read
bottom of page